NUVEEN DOW 30 DYNAMIC OVERWR (DIAX) Fundamental Analysis & Valuation

NYSE:DIAX • US67075F1057

Current stock price

14.1 USD
-0.13 (-0.91%)
At close:
14.1 USD
0 (0%)
After Hours:

This DIAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DIAX Profitability Analysis

1.1 Basic Checks

  • In the past year DIAX has reported negative net income.
  • Of the past 5 years DIAX 4 years were profitable.
  • In the past 5 years DIAX always reported negative operating cash flow.
DIAX Yearly Net Income VS EBIT VS OCF VS FCFDIAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • The 3 year average ROIC (0.77%) for DIAX is below the current ROIC(0.92%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.39%
ROE -4.42%
ROIC 0.92%
ROA(3y)8.52%
ROA(5y)6.91%
ROE(3y)8.58%
ROE(5y)7.01%
ROIC(3y)0.77%
ROIC(5y)0.8%
DIAX Yearly ROA, ROE, ROICDIAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

  • In the last couple of years the Operating Margin of DIAX has declined.
  • DIAX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 56.42%
PM (TTM) N/A
GM 58.6%
OM growth 3Y-5.24%
OM growth 5Y-4.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.69%
GM growth 5Y-5.27%
DIAX Yearly Profit, Operating, Gross MarginsDIAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 400 600 800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DIAX Health Analysis

2.1 Basic Checks

  • DIAX has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DIAX has less shares outstanding
  • DIAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DIAX Yearly Shares OutstandingDIAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DIAX Yearly Total Debt VS Total AssetsDIAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 64.43 indicates that DIAX is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for DIAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 64.43
ROIC/WACCN/A
WACCN/A
DIAX Yearly LT Debt VS Equity VS FCFDIAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • DIAX has a Current Ratio of 0.35. This is a bad value and indicates that DIAX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.35 indicates that DIAX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
DIAX Yearly Current Assets VS Current LiabilitesDIAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. DIAX Growth Analysis

3.1 Past

  • DIAX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -129.76%.
  • Looking at the last year, DIAX shows a small growth in Revenue. The Revenue has grown by 5.85% in the last year.
  • DIAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.73% yearly.
EPS 1Y (TTM)-129.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.76%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-8.02%
Revenue growth 5Y-5.73%
Sales Q2Q%5.57%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DIAX Yearly Revenue VS EstimatesDIAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

Find the best growth stocksShow best growing peers

0

4. DIAX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DIAX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DIAX Price Earnings VS Forward Price EarningsDIAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DIAX Per share dataDIAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DIAX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 8.54%, DIAX is a good candidate for dividend investing.
  • DIAX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 8.54%

5.2 History

  • DIAX has paid a dividend for at least 10 years, which is a reliable track record.
  • DIAX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years4
DIAX Yearly Dividends per shareDIAX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
DIAX Yearly Income VS Free CF VS DividendDIAX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

More info and screens

Find the best dividend stocksShow peers with best dividend

DIAX Fundamentals: All Metrics, Ratios and Statistics

NUVEEN DOW 30 DYNAMIC OVERWR

NYSE:DIAX (3/27/2026, 8:12:04 PM)

After market: 14.1 0 (0%)

14.1

-0.13 (-0.91%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners39.16%
Inst Owner Change-6.15%
Ins OwnersN/A
Ins Owner Change0%
Market Cap512.82M
Revenue(TTM)12.85M
Net Income(TTM)-27.30M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.54%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years4
Ex-Date03-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 39.91
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.35
BVpS16.97
TBVpS16.97
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.39%
ROE -4.42%
ROCE 1.17%
ROIC 0.92%
ROICexc 0.92%
ROICexgc 0.92%
OM 56.42%
PM (TTM) N/A
GM 58.6%
FCFM N/A
ROA(3y)8.52%
ROA(5y)6.91%
ROE(3y)8.58%
ROE(5y)7.01%
ROIC(3y)0.77%
ROIC(5y)0.8%
ROICexc(3y)0.77%
ROICexc(5y)0.8%
ROICexgc(3y)0.77%
ROICexgc(5y)0.8%
ROCE(3y)0.97%
ROCE(5y)1.02%
ROICexgc growth 3Y-14.4%
ROICexgc growth 5Y-10.2%
ROICexc growth 3Y-14.4%
ROICexc growth 5Y-10.2%
OM growth 3Y-5.24%
OM growth 5Y-4.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.69%
GM growth 5Y-5.27%
F-ScoreN/A
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 64.43
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-8.02%
Revenue growth 5Y-5.73%
Sales Q2Q%5.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.12%
EBIT growth 3Y-12.84%
EBIT growth 5Y-9.73%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NUVEEN DOW 30 DYNAMIC OVERWR / DIAX Fundamental Analysis FAQ

What is the fundamental rating for DIAX stock?

ChartMill assigns a fundamental rating of 2 / 10 to DIAX.


Can you provide the valuation status for NUVEEN DOW 30 DYNAMIC OVERWR?

ChartMill assigns a valuation rating of 0 / 10 to NUVEEN DOW 30 DYNAMIC OVERWR (DIAX). This can be considered as Overvalued.


Can you provide the profitability details for NUVEEN DOW 30 DYNAMIC OVERWR?

NUVEEN DOW 30 DYNAMIC OVERWR (DIAX) has a profitability rating of 1 / 10.


What is the financial health of NUVEEN DOW 30 DYNAMIC OVERWR (DIAX) stock?

The financial health rating of NUVEEN DOW 30 DYNAMIC OVERWR (DIAX) is 5 / 10.